Predictors of virological response to a combination therapy with pegylated interferon plus ribavirin including virus and host factors.

Hepat Res Treat · 2010 · PMC3003995 · PMID 21188200

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Nevertheless, the results showed a trend toward a higher SVR rate by extending therapy from 48 to 72 weeks in patients with delayed virological response. 3.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.